The FTSE 250 group reported a pre-tax profit of US$53.6mln for the 12 months ended 31 March, compared to a US$41mln loss the year before, while revenues jumped 11.2% to US$710.6mln.
Sophos also upped its final dividend for the year by 6% to US$0.052 per share.
The improved earnings were helped by a 16% increase in subscription revenues, with the company also citing “continued strong demand” for its next generation products. Billings, however, fell 1.1% in the year to US$760.3mln.
Looking ahead, Sophos said its subscription business would provide a driver for “continued future revenue growth” and a return to operating profit margin leverage after its 2020 financial year.
Chief executive Kris Hagerman added that demand for cybersecurity remained “robust” and that the group's next-gen products aligned well with demands for “cloud-native solutions, centralised administration, integrated products, AI-powered protection, openness, and a service-oriented approach to security”.
The improved results came as a relief to investors, who had previously been alarmed by a profit warning from the group back in November, when news of slower customer orders sent the stock tumbling.
The gloom had continued in a January update, when Sophos had warned that its performance had continued to be subdued into the new year.
However, in lunchtime trading the shares were singing a different tune and were up 14.2% at 388.4p.
Broker takes 'wait-and-see' approach
In a note to clients, analysts at Shore Capital said that their estimates for Sophos were “understandably cautious” citing the company’s recent history of missing estimates and said that the market would “likely take a wait-and-see approach”.
The broker added that if billings growth improved as expected in the 2020 fiscal year valuations “should revert to a more normalised level” and could potentially unlock 20% upside from the shares.
Shore Capital currently rates Sophos at 'hold' with a target price of 340p.
Results “first step” in restoring credibility, says analyst
Nicholas Hyett, equity analyst at Hargreaves Lansdown, said that after being “caught out repeatedly last year with over-optimistic forecasts”, the better than expected performance from Sophos went some way into patching up its “damaged credibility”.
“Having seen billings growth crumble last year management had warned the market to expect a modest decline in total billings for the full year. In the event Sophos has been able to deliver better than expected numbers, billings now are crucial to revenue performance in the future.”
Hyett added that while a full rehabilitation was “some way off”, the latest figures were “the first step on the road”.
--Adds analyst comment and updates share price--